News

US Job Market Gains 123.7K Jobs, Salaries Decline

US Job Market Gains 123.7K Jobs, Salaries Decline

Job Numbers Looking Rosy...But Not All Smile

So, here we go again with the numbers game, people. Revelio Labs is out with their May 2026 job market stats, blazing the trail outside of government reports with a neat gain of 123,700 jobs. On the surface, it looks like all sunshine and rainbows. But, folks, dig a little deeper, and you’ll see this train ain't carrying everybody.

Sectors on the Move

Now, don’t cue the victory dance just yet. Sure, the Public Administration, Healthcare, and Professional Services are pounding their chests with the biggest job increases. Nice work if you can get it with names like the US Government and big players like Adventist Health System leading the charge.

The economy's layers are thick. Public sector grabs big, but Retail's trailing behind.

Meanwhile, the folks in Retail, and dear ol’ Leisure and Hospitality—think Starbucks and your local Dunkin'—aren't quite so lucky, shedding positions faster than a snake in summer. Overall, labor's growing might be a win at first blush, but it's tough everywhere you look under the hood.

Wages Are No Bed of Roses

There's a storm brewing over salaries, too. Overall, they're on a slippery slope, down 0.41% from April. Imagine that: a steady climb in one hand and a salary drop in the other. The Information sector might be outliers, enjoying a rare salary bump of 4.47%, but most are seeing those pay slips shrink around them.

  • Agriculture, Forestry, Fishing: up 0.19%
  • Mining, Quarrying, Oil & Gas: down 1.60%
  • Utilities: down 0.60%
  • Education & Health: up 0.71%

This mixed bag only hammers home the volatility lurking in the job market's deeper nooks. A peek at your paycheck could easily be sobering.

The Lay of the Land

Make no mistake, Revelio's doing the heavy lifting, crunching over 100 million profiles to provide a bird’s-eye view of what we're dealing with. It's workforce analytics on a scale that blows those traditional surveys out of the water. We could all use a bit of that transparency these days, don’t you think?

Navigating Uneven Waters

Chin up because there's more to glean here. The stats tell us salaries from new job postings are nudging down, which means companies might be getting stingy with the cash. Couple that trend with job attrition taking a back step, and it's clear businesses are keeping workers on a tighter rein.

Sure, attrition dipping could mean people are clinging tighter to their jobs. That's one way to look at it. But on the flip side, it might mean we’ve hit a plateau with nowhere to go but down. No wonder most are staying put.

“The labor market's like a tangled fishing line—strong in spots but twisted and uneven,” remarked Lisa Simon, Chief Economist.

Investors, Here's Your Weather Report

For investors with skin in the game, this is your wake-up. The conditions are ripe for cautious maneuvering. The stretches that are healthy, like public administration, could be fertile grounds for consistent returns, while sectors dragging their feet may need a pause from heavy bets.

And keep an eye on those wage trends, especially if an area you're betting on looks like it's slashing salaries instead of growing them. It might be time to ask some tough questions or rethink your strategy.

Final Thoughts

In essence, the U.S. job market is a land of stark contrasts, showing plenty of promise if you look at certain pieces—and harsh realities if you turn your gaze elsewhere. Revelio’s data breakdown slices through the fog. The clearer your view, the shrewder your plays can be, no doubt. Just don’t bank on any breaks being as smooth as clockwork, because these wrinkles take time to iron out.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 20

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 21

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading